Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Company Summary

Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is headquartered in Nedlands, Australia.

Health Care
Biotechnology
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Announcements

Published at:

Link

No items found.

Articles